A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study
Brian M. Slomovitz, Virginia L. Filiaci, Joan L. Walker, Michael C. Taub, Karen A. Finkelstein, John W. Moroney, Aimee C. Fleury, Carolyn Y. Muller, Laura L. Holman, Larry J. Copeland, David S. Miller, Robert L. Coleman
Topics & Concepts
MedicineLetrozoleEverolimusOncologyInternal medicineHormonal therapyRandomized controlled trialFoundation (evidence)GynecologyPhases of clinical researchClinical trialHormoneChemotherapyEndometrial and Cervical Cancer TreatmentsEstrogen and related hormone effectsOvarian cancer diagnosis and treatment